Study guide
12.1 PFT Reporting Standards, Tabular Formats, and Interpretation Graphics
Certified Pulmonary Function Technologist CPFT
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Overview & NBRC Certification Requirements
1.1 NBRC PFT Exam Logistics, Format, and Scoring Criteria 1.2 Scope of Practice, Candidate Admission Pathways, and Credential Maintenance 1.3 Professional Standards, Ethics, and Patient Safety in Diagnostic Testing
2 Chapter 2: Spirometry Equipment & Sensors
2.1 Volume-Displacement Spirometers: Water-Seal, Rolling-Seal, Bellows 2.2 Flow-Sensing Pneumotachometers: Fleisch, Lilly, Vortex, Turbine, Pitot Tube, Ultrasonic 2.3 Calibration Standards & 3-Liter Syringe Quality Control Verification
3 Chapter 3: Body Plethysmography & Hardware
3.1 Body Plethysmograph Principles: Pressure, Volume, and Variable-Pressure-Constant-Volume Design 3.2 Plethysmograph Calibration, Pressure Transducers, and Shutter Mechanics 3.3 Quality Control, Isothermal Corrections, and Leak Detection in Plethysmography
4 Chapter 4: Gas Analyzers, Environmental Sensors, & Infection Control
4.1 Rapid and Multi-Gas Analyzers: Infrared, Zirconium, Mass Spec, Electrochemical, Thermal Conductivity 4.2 Environmental Sensors, Barometric Pressure, Temperature, and BTPS Correction Factors 4.3 Infection Control, Equipment Decontamination, Disposable Filters, and Spaulding Classification 4.4 Monitors: Pulse Oximeters, Blood Pressure Devices, and ECG Equipment 4.5 Gas Delivery Systems, Valves, Absorbers, and Aerosol / Inhaler Devices
5 Chapter 5: Spirometry Protocols & ATS/ERS Criteria
5.1 Forced Vital Capacity (FVC) and Slow Vital Capacity (SVC) Testing Protocols 5.2 ATS/ERS Spirometry Acceptability, Repeatability, and Usability Criteria 5.3 Peak Expiratory Flow Rate (PEFR), Maximum Voluntary Ventilation (MVV), and Flow-Volume Loops
6 Chapter 6: Lung Volume Determination Protocols
6.1 Open-Circuit Nitrogen Washout Method: Principles, Equipment, and Calculation 6.2 Closed-Circuit Helium Dilution Method: Principles, Equipment, and Calculation 6.3 Thoracic Gas Volume (TGV/FRCpleth) and Comparison of Lung Volume Methods
7 Chapter 7: Diffusing Capacity & Bronchial Challenge Testing
7.1 Single-Breath Carbon Monoxide Diffusing Capacity (DLCO) Testing Protocol 7.2 DLCO Calculations, Hemoglobin/COHb/Altitude Corrections, and VA 7.3 Bronchial Provocation Testing: Methacholine Challenge, Exercise-Induced Bronchospasm, and EIB Protocols 7.4 Inhaled Medication Delivery Technique and Patient Education
8 Chapter 8: Cardiopulmonary Exercise & ABG Testing
8.1 Cardiopulmonary Exercise Testing (CPET) Protocols, VO2max, and Anaerobic Threshold 8.2 Six-Minute Walk Test (6MWT) Protocol, Desaturation Monitoring, and O2 Titration 8.3 Arterial Blood Gas (ABG) Sampling, Allen Test, Analyzer Maintenance, and Quality Control 8.4 Pulse Oximetry and Oxygen Assessment: Principles, Limitations, and Titration Data 8.5 CO-Oximetry / Hemoximetry: Measurement, Dyshemoglobins, and Clinical Implications 8.6 Exercise Monitoring Data: Blood Pressure Response and ECG Rhythm Analysis
9 Chapter 9: Reference Values & PFT Calculations
9.1 Predicted Value Equations, Reference Populations, and GLI 2012 / ATS/ERS 2022 Standards 9.2 BTPS, STPD, and ATPS Conversion Formulas and Calculations 9.3 Gas Exchange Formulas, Alveolar Air Equation, and Mechanical Calculations
10 Chapter 10: Pattern Recognition & Clinical PFT Interpretation
10.1 Obstructive Ventilatory Defects: Asthma, COPD, Emphysema, Chronic Bronchitis, Bronchiectasis 10.2 Restrictive Ventilatory Defects: Parenchymal, Chest Wall, and Neuromuscular Disorders 10.3 Mixed Ventilatory Defects, Isolated Diffusion Defects, and Reversibility Protocols
11 Chapter 11: Artifact Recognition & Quality Assurance
11.1 Spirometry Artifacts: Hesitation, Coughing, Early Termination, Glottic Closure, Leak 11.2 Lung Volume and DLCO Artifacts: Panting Frequency, Shutter Leaks, Breath-Hold Failure 11.3 Quality Control Charts, Westgard Rules, and Laboratory Quality Assurance
12 Chapter 12: Documentation, Compliance, & Emergency Safety
12.1 PFT Reporting Standards, Tabular Formats, and Interpretation Graphics 12.2 CPT Billing Codes, ICD-10 Coding, HIPAA Privacy, and EHR Compliance 12.3 Emergency Preparedness, Contraindications, and Patient Safety Management in PFT Lab
13 Chapter 13: Specialized Procedures, Home Testing & Longitudinal Data
13.1 Respiratory Muscle Strength: MIP, MEP, SNIP, and Cough Peak Flow 13.2 Sputum Sample Collection: Spontaneous and Induced Specimens 13.3 Home Testing Instruction: Home Spirometry, Peak Flow Diaries, and Home Oximetry 13.4 Pediatric Pulmonary Function Testing and Upright Versus Supine Spirometry 13.5 Serial Pulmonary Function Testing, Clinical History, Demographics, and Laboratory Quality Management
12.1 PFT Reporting Standards, Tabular Formats, and Interpretation Graphics
Key Takeaways Explain This Topic AI
ATS/ERS standard PFT reports must display baseline measured values, predicted values, lower limit of normal (LLN), percentage of predicted, and post-bronchodilator responses with absolute and percentage changes.
The Lower Limit of Normal (LLN), calculated as the 5th percentile of a reference population (Z-score < -1.645), prevents over-diagnosis of obstruction in elderly patients compared to fixed percentage cutoffs like FEV1/FVC < 0.70.
Bronchodilator responsiveness is reported against the classic 12% AND 200 mL rule or the ATS/ERS 2022 rule of a change greater than 10% of predicted, and the report must state which criterion it applied.
Graphical reporting of flow-volume loops and volume-time curves provides essential visual quality indicators for recognizing artifacts like early termination, cough, glottic closure, and variable effort.
Severity of airflow obstruction is graded by three distinct published schemes (GOLD 1-4 by percent predicted, the ATS/ERS 2005 impairment bands, and ATS/ERS 2022 z-score bands), so a report must name the scheme it used.
Last updated: August 2026
12.1 PFT Reporting Standards, Tabular Formats, and Interpretation Graphics
Standardized reporting of pulmonary function test (PFT) data is essential for accurate clinical interpretation, longitudinal tracking of disease progression, and effective communication across interprofessional healthcare teams. According to the Joint American Thoracic Society (ATS) and European Respiratory Society (ERS) Task Force guidelines for PFT standardization, diagnostic reports must follow structured tabular formats, incorporate age- and height-appropriate reference equations, apply mathematically sound lower limits of normal (LLN), and display high-resolution interpretation graphics.
ATS/ERS Standardized PFT Report Structure
A comprehensive pulmonary diagnostic report must contain clear, organized sections that allow interpreting physicians and clinicians to systematically evaluate physiological parameters. A standardized PFT report is organized into five primary functional zones:
Patient Demographics & Test Conditions: Full name, medical record number (MRN), date of birth, age, biological sex, standing height, weight, race/ethnicity reference set utilized, ambient temperature, barometric pressure, testing location, and technician identification.
Spirometry Data Table: Forced Vital Capacity (FVC), Forced Expiratory Volume in 1 second (FEV1), FEV1/FVC ratio, Peak Expiratory Flow Rate (PEFR), and Forced Expiratory Flow between 25% and 75% of FVC (FEF25-75%).
Lung Volume Data Table (if performed): Total Lung Capacity (TLC), Functional Residual Capacity (FRC via plethysmography, helium dilution, or nitrogen washout), Residual Volume (RV), and RV/TLC ratio.
Diffusing Capacity Data Table (if performed): Carbon Monoxide Diffusing Capacity (DLCO), Alveolar Volume (VA), DLCO/VA ratio (KCO), unadjusted DLCO, and hemoglobin-adjusted DLCO.
Graphical Displays: Superimposed flow-volume loops (pre- and post-bronchodilator overlay) and volume-time curves showing individual effort maneuver tracings.
Demographics, Reference Equations, and BTPS Conditions
Accurate interpretation relies entirely on comparing a patient's measured physical performance against predicted reference values derived from healthy, non-smoking population samples.
Impact of Anthropometric Variables
Standing Height: The single most critical determinant of predicted lung volumes. For patients with thoracic spinal deformities (e.g., severe kyphoscoliosis), standing height underestimates true thoracic length. Technologists must measure arm span (substernal notch to fingertip or fingertip-to-fingertip) and apply conversion equations to establish correct predicted values.
Age: Lung volumes increase during childhood, peak in early adulthood (ages 20–25), and undergo steady age-related decline thereafter due to loss of lung elastic recoil.
Biological Sex: Males possess larger lung volumes than females of equal age and height due to larger thoracic dimensions and lung parenchyma volume.
Reference Equations & GLI Standard: Historically, ethnic correction factors were applied to reference equations. Modern ATS/ERS 2019/2022 guidelines strongly recommend race-neutral reference equations, such as the Global Lung Function Initiative (GLI) multi-ethnic equations, to eliminate racial bias in diagnostic thresholding.
Body Temperature, Pressure, and Saturated (BTPS) Adjustments
All exhaled volume measurements must be converted from ambient spirometer conditions (ATPS: Ambient Temperature, Pressure, Saturated with water vapor) to body conditions ( BTPS : 37°C, ambient barometric pressure, saturated with water vapor at 47 mmHg). Because gas contracts when cooled from body temperature (37°C) to room temperature (e.g., 22°C), failure to apply BTPS factors results in an artificial underestimation of exhaled lung volumes by 6% to 10%.
Lower Limit of Normal (LLN) vs. Fixed Percentage Cutoffs
Evaluating whether a parameter is abnormal requires a rigorous statistical threshold. +-----------------------------------------------------------------------------------+
- | STATISTICAL THRESHOLDS: LLN VS. FIXED CUTOFF |
- +-----------------------------------------------------------------------------------+
- | LOWER LIMIT OF NORMAL (LLN - RECOMMENDED ATS/ERS) |
- | - Defined as the 5th percentile of a healthy population distribution. |
- | - Corresponds to a Z-Score < -1.645 standard deviations below predicted mean. |
- | - Dynamically adjusts for age, sex, and height. |
- | - Eliminates over-diagnosis of obstruction in elderly and under-diagnosis in young.|
- +-----------------------------------------------------------------------------------+
- | FIXED 70% CUTOFF (FEV1/FVC < 0.70 - GOLD CRITERIA LIMITATION) |
- | - Applies a rigid cutoff ratio of 0.70 for all individuals regardless of age. |
- | - False Positives: Over-diagnoses obstruction in healthy elderly patients due to |
- | normal age-related decline in FEV1/FVC. |
- | - False Negatives: Under-diagnoses obstruction in young adults whose normal ratio |
- | exceeds 0.85. |
- +-----------------------------------------------------------------------------------+
- Z-Score Interpretation
Modern PFT software calculates Z-scores (standard deviation scores):
Z-score = 0: Measured value equals exact predicted mean.
Z-score between -1.645 and +1.645: Normal physiological range (5th to 95th percentile).
Z-score < -1.645: Abnormal value below the Lower Limit of Normal (LLN).
Standard Tabular Data Layout & Reversibility Calculations
PFT reports format data in standardized multi-column tables to display pre-test values, predicted values, percentages of predicted, and post-bronchodilator responses.
Parameter Baseline Measured Predicted Value Lower Limit of Normal (LLN) % Predicted Post-BD Measured Absolute Change % Change
- FVC (L) 3.20 4.10 3.25 78% 3.65 +0.450 L (+450 mL) +14.1%
- FEV1 (L) 1.85 3.20 2.50 58% 2.25 +0.400 L (+400 mL) +21.6%
- FEV1/FVC (%) 57.8% 78.0% 68.5% -- 61.6% +3.8% --
- FEF25-75% (L/s) 1.10 3.40 2.10 32% 1.60 +0.500 L/s +45.5%
- Mathematical Formulas for Bronchodilator Responsiveness
To evaluate whether airflow limitation is reversible following inhaled short-acting beta-agonist (SABA) administration:
Absolute Volume Change (mL or L): Absolute Change = Post-BD Measured Value − Pre-BD Measured Value \text{Absolute Change} = \text{Post-BD Measured Value} - \text{Pre-BD Measured Value} Absolute Change = Post-BD Measured Value − Pre-BD Measured Value
Percentage Change from Baseline (%): Percentage Change = ( Post-BD Value − Pre-BD Value Pre-BD Value ) × 100 \text{Percentage Change} = \left( \frac{\text{Post-BD Value} - \text{Pre-BD Value}}{\text{Pre-BD Value}} \right) \times 100 Percentage Change = ( Pre-BD Value Post-BD Value − Pre-BD Value ) × 100
Two criteria belong on a modern report. The classic ATS/ERS rule calls a response positive when FEV1 or FVC rises by at least 12% AND at least 200 mL over baseline. The ATS/ERS 2022 interpretive standard calls a response positive when FEV1 or FVC rises by more than 10% of the predicted value . A compliant report states which criterion produced the printed conclusion. In the table above, FVC rose 0.450 L against a predicted 4.10 L (11.0% of predicted) and FEV1 rose 0.400 L against a predicted 3.20 L (12.5% of predicted), so this study is positive under both frameworks.
Graphical Displays: Flow-Volume Loops and Volume-Time Curves
Visual Inspection of graphics is mandatory to validate numerical data and detect technical quality artifacts.
Flow-Volume Loops
The flow-volume loop plots expiratory and inspiratory airflow (L/s) on the vertical y-axis against exhaled/inhaled volume (L) on the horizontal x-axis:
Expiratory Curve: Rapid rise to Peak Expiratory Flow Rate (PEFR), followed by a smooth, linear effort-independent decay toward total exhaled volume (FVC).
Diagnostic Patterns:
Obstructive Pattern: Concave "scooping" of the expiratory limb during mid-to-late exhalation.
Restrictive Pattern: Preserved, narrow, "witch's hat" shape with normal/steep expiratory slope but reduced absolute volume width.
Fixed Upper Airway Obstruction: Flattened top and bottom (both expiratory and inspiratory limbs truncated).
Variable Extrathoracic Obstruction: Flattened inspiratory loop with normal expiratory loop.
Quality Artifact Identification
Cough in First Second: Multiple sharp flow oscillations during the first second of exhalation; invalidates FEV1.
Glottic Closure / Early Termination: Abrupt vertical drop of expiratory flow to zero before reaching exhalation plateau; invalidates FVC.
Variable Effort: Hesitant start, variable peak flow, or jagged expiratory curve; fails ATS repeatability criteria.
Excessive Back-Extrapolated Volume (BEV): Hesitant start resulting in BEV > 5% of FVC or > 0.100 L; invalidates test maneuver.
- Algorithmic Interpretation and Severity Staging
- Interpretation follows a systematic diagnostic algorithm: Evaluate FEV1/FVC Ratio
- |
- +-------------------+-------------------+
- | |
- FEV1/FVC < LLN FEV1/FVC >= LLN
- | |
- OBSTRUCTIVE PATTERN Evaluate FVC
- | |
- Stage Severity via +---------------+---------------+
- FEV1 % Predicted | |
- FVC < LLN FVC >= LLN
- | |
- SUSPECT RESTRICTION NORMAL SPIROMETRY
- |
- Confirm via TLC
- Severity Grading: Name the Scheme Before You Quote a Number
Once an obstructive defect is established, severity is graded from FEV1 — but three published schemes use three different sets of cut points. A report that prints a severity word without naming its scheme is ambiguous.
Scheme Basis Bands
GOLD 1–4 Post-bronchodilator FEV1 % predicted ≥ 80 % \ge 80\% ≥ 80% / 50 50 50 – 79 % 79\% 79% / 30 30 30 – 49 % 49\% 49% / < 30 % < 30\% < 30%
ATS/ERS 2005 impairment FEV1 % predicted Mild > 70 % > 70\% > 70% ; Moderate 60 60 60 – 69 % 69\% 69% ; Moderately severe 50 50 50 – 59 % 59\% 59% ; Severe 35 35 35 – 49 % 49\% 49% ; Very severe < 35 % < 35\% < 35%
ATS/ERS 2022 interpretive FEV1 z-score Mild − 1.65 -1.65 − 1.65 to − 2.50 -2.50 − 2.50 ; Moderate − 2.51 -2.51 − 2.51 to − 4.00 -4.00 − 4.00 ; Severe < − 4.00 < -4.00 < − 4.00
The ATS/ERS 2022 statement recommends the z-score scheme because a fixed percent-predicted band means very different things at age 25 and at age 80. Percent predicted stays on reports for continuity and because payer and disability rules still reference it.